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Abstract
Background: Advance care planning (ACP) is a process whereby patients prepare for medical decision-making.
The traditional objective of ACP has focused on the completion of advance directives. We have developed a new
paradigm of ACP focused on preparing patients and their loved ones for communication and informed medical
decision-making. To operationalize this new paradigm of ACP, we created an interactive, patient-centered website
called PREPARE (www.prepareforyourcare.org) designed for diverse older adults.
Methods/Design: This randomized controlled trial with blinded outcome assessment is designed to determine the
efficacy of PREPARE to engage older Veterans in the ACP process. Veterans who are ≥ 60 years of age, have ≥ two
medical conditions, and have seen a primary care physician ≥ two times in the last year are being randomized to
one of two study arms. The PREPARE study arm reviews the PREPARE website and an easy-to-read advance
directive. The control arm only reviews the advance directive. The primary outcome is documentation of an
advance directive and ACP discussions. Other clinically important outcomes using validated surveys include ACP
behavior change process measures (knowledge, contemplation, self-efficacy, and readiness) and a full range of ACP
action measures (identifying a surrogate, identifying values and goals, choosing leeway or flexibility for the
surrogate, communicating with clinicians and surrogates, and documenting one’s wishes). We will also assess
satisfaction with decision-making and Veteran activation within primary care visits by direct audio recording. To
examine the outcomes at 1 week, 3 months, and 6 months between the two study arms, we will use mixed effects
linear, Poisson, or negative binomial regression and mixed effects logistic regression.
Discussion: This study will determine whether PREPARE increases advance directive completion rates and engagement
with the ACP process. If PREPARE is efficacious, it could prove to be an easy and effective intervention to help older
adults engage in the ACP process within or outside of the medical environment. PREPARE may also help older adults
communicate their medical wishes and goals to their loved ones and clinicians, improve medical decision-making, and
ensure their wishes are honored over the life course.
Trial registration: ClinicalTrials.gov NCT01550731. Registered on 8 December 2011.
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Background
More than 10 million Veterans who are over age 65 will
face complex decisions over the course of chronic illness
[1], yet most are unprepared to do so [2, 3]. Inadequate
preparation leads to uninformed choices, lack of em-
powerment in clinical encounters, and added stress for
Veterans, their families and surrogate decision makers
[4–8]. Interventions to prepare Veterans for complex
decisions and to communicate their wishes and goals for
medical care to surrogates and clinicians are lacking.
Advance care planning is a process whereby people
identify and communicate their goals for future medical
care. In the old, narrow paradigm of advance care plan-
ning (ACP), the objective was focused on having patients
make decisions about life-prolonging procedures, such
as cardiac resuscitation, and to document these choices
in an advance directive. However, Veterans are making
many decisions over the course of their lives, and many
Veterans and their loved ones are unprepared to make
these decisions or to understand and complete legal
advance directive forms, which are often used for
advance care planning. More preparation is needed to
achieve comprehensive ACP, and ACP guides must meet
the literacy needs of older adults and Veterans (5th-grade
level), as well as address patients’ diverse cultural needs
[9–12].
Our prior work addressed some of these barriers to
meaningful ACP for older adults. We designed and
tested an advance directive written at a 5th-grade reading
level among 205 chronically ill, diverse, older adults at a
county hospital in San Francisco. The easy-to-read dir-
ective was preferred over a standard directive, especially
among those with limited health literacy. It also resulted
in significantly greater 6-month advance directive
completion rates, doubling the rates from baseline [12].
This easy-to-read advance directive is currently being
disseminated in several languages in California [13].
Although the easy-to-read advance directive was
shown to be an improvement over standard forms,
through additional formative work, we found that most
patients go through a series of ACP behavioral steps that
extend beyond simply filling out an advance directive.
For example, 6 months after exposure to the easy-to-read
advance directive, only 13 % completed an advance direct-
ive whereas 61 % of older adults contemplated ACP, 56 %
discussed ACP with family or friends and 22 % dis-
cussed ACP with clinicians [14]. These data support
the need to engage patients in a full range of ACP
activities in addition to having them complete legal
advance directive forms.
Based on our prior work [15] and the work of others
[16, 17], we developed and published an updated para-
digm of comprehensive ACP that shifts the focus from
completion of advance directives to preparing patients
to communicate their goals of care with surrogates
and to actively participate with clinicians in making
the best possible in-the-moment decisions [11]. To
operationalize this new paradigm, we created an easy-to-
read, culturally-appropriate website called PREPARE
(www.prepareforyourcare.org). PREPARE is targeted to a
5th- grade reading level and was designed to be completed
outside of a clinical setting without supervision or facilita-
tion. PREPARE includes communication training on how
to 1) choose and ask a surrogate; 2) clarify and communi-
cate one’s values; 3) discuss leeway in surrogate’s decisions
(allow surrogates to use their best judgment); 4) inform
clinicians, family, and friends of one’s decisions; and
5) ask clinicians appropriate questions to make in-
formed medical choices [11]. Extensive videos are
used to demonstrate, through modeling, how to make
ACP decisions and to communicate with surrogates
and clinicians [15, 18–20]. Our pilot findings showed that,
among diverse older adults, PREPARE significantly
improved engagement and behavior change in ACP.
Furthermore, it was rated a 9 out of 10 for ease of use,
despite limited health literacy and lack of computer
experience in this cohort of older adults [15].
The goal of this randomized controlled trial is to
determine the efficacy of PREPARE to engage Veterans
in the full comprehensive process of ACP. Consistent
with prior studies in the field, our primary outcome is
advance directive completion. In addition, important
secondary outcomes include identifying goals for medical
care, communicating with surrogates and clinicians, and
making informed medical decisions.
Methods/Design
Theoretical foundation
The conceptual framework for the PREPARE intervention
and this study has been previously published [15]. In brief,
this work rests on the foundation of Social Cognitive
Theory, the Interpersonal Communication Competence
Model, and Behavior Change Theory [18, 19, 21]. ACP is a
complex behavior that often involves people undergoing a
series of behavior change steps, which are influenced by
knowledge, self-efficacy and readiness. Behavior change is
highly influenced by social norms and modeling of these
behaviors by others. This framework demonstrates that
PREPARE was designed to address important moderator
variables such as culture, religion, and literacy. PREPARE
incorporates important aspects from the aforementioned
theories by including training in communication, goal
setting exercises and videos that demonstrate and model
ACP behaviors. PREPARE is designed to address modifi-
able mediators such as knowledge, self-efficacy, and readi-
ness, which then allows individuals to progress through
the behavior change stages from pre-contemplation to
contemplation and then to readiness and action for the
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multiple behaviors that compose the process of ACP.
Based on the conceptual framework, we developed and
validated the ACP Engagement Survey to measure the full
construct and process of ACP [22]. Behavioral process
measures of behavior change include knowledge, contem-
plation, self-efficacy, and readiness, whereas ACP actions
include identification of a surrogate, identification of
values and goals, choosing the level of leeway or flexibility
in decision-making for the surrogate, communicating this
information with clinicians and surrogate decision makers,
and documenting one’s wishes.
Aims and primary hypotheses
The primary hypothesis of this study is that older
Veterans randomized to the PREPARE arm (the PREPARE
website plus the easy-to-read advance directive), compared
to the control arm (the easy-to-read advance directive
alone), will have increased rates of ACP documentation in
their medical record (advance directives, clinicians notes,
code status orders). Because this is the standard outcome
measure for advance care planning, it is the outcome on
which we calculated our sample size (see Sample Size Sec-
tion). However, ACP consists of several behavioral
processes (knowledge, contemplation, self-efficacy, and
readiness) for several discrete ACP behaviors, including
identifying surrogates, identifying values, and communicat-
ing this information with clinicians, surrogates, and other
loved ones. Therefore, we feel our secondary outcomes
and hypotheses are just as clinically meaningful. The
secondary hypotheses of this study are that older Veterans
randomized to the PREPARE arm, compared to the control
arm, will have greater engagement in ACP including
behavior change process measures and additional ACP
actions beyond advance directive documentation as
measured by a validated survey [22]. Secondary hypotheses
also include greater Veteran activation and clinician
responsiveness within the clinical encounter as measured
by audio-recording a subset of clinical visits, Veteran satis-
faction with clinician communication, Veteran engagement
and satisfaction with decision-making, surrogate-reports of
Veteran engagement in ACP behaviors, and fewer reported
barriers to ACP for the PREPARE versus control arm.
Other outcomes include comparisons of acceptability and
usability of the PREPARE website plus an easy-to-read ad-
vance directive versus an advance directive alone (Table 2).
Setting
The study is a randomized controlled trial with blinded
outcome ascertainment conducted at the San Francisco
Veterans Administration Medical Center (SFVAMC).
Overview of study procedures
Veteran recruitment occurs in waves to target upcoming
primary care clinic appointments and to allow time for
recruitment and scheduling of a baseline interview (Fig. 1,
Study Flowchart). Veterans are then randomized to the
PREPARE arm (PREPARE website [15], action plan creation
within the website, and provision of PREPARE logins and
PREPARE materials in pamphlet, booklet and DVD formats
to take home) plus an easy-to-read advance directive [12],
or the control arm which only receives the easy-to-read ad-
vance directive. Outcomes pertaining to ACP engagement
behavior are assessed at 1 week, 3 months, and 6 months
between the two study arms (Table 2).
Participants
Table 1 includes a list of all inclusion and exclusion
criteria. Briefly, Veterans are eligible for inclusion in this
study if they are 60 years of age and older and have two
or more chronic or severe medical conditions as deter-
mined by any of the ICD-9 codes listed in the Charlson
or Elixhauser measures of comorbidity [23, 24]. The
Charlson comorbidity index uses ICD-9 codes associated
with 22 comorbid conditions such as heart disease and
cancer, and the Elixhauser uses 30 acute and chronic
conditions associated with in-patient mortality. We use
the inclusion criteria of two or more chronic or severe
medical conditions to identify a cohort of patients who
have medical conditions that may require medical
decision-making. Patients also have to have been seen by
a primary care clinician at the SFVAMC two or more
times in the past year (a marker for established primary
care) and have two or more additional outpatient or in-
patient visits in the past year (a marker of disease sever-
ity and frequent access to care). Patients are excluded if
they have dementia; are blind, deaf, or psychotic as de-
termined by their clinician, chart review or study staff;
do not have a phone for study contact and follow-up in-
terviews; or do not live within 30 miles of the SFVAMC,
which would make an in-person baseline interview diffi-
cult (Table 1). We chose to focus our study population
on older adults with chronic illness, as our preliminary
work suggests that patients may be less likely to engage
in ACP if they perceive themselves as “too healthy” [25].
In addition, we chose not to exclude patients with ter-
minal or serious illness because our goal is to move ACP
upstream in patients’ disease trajectories and to assess
the efficacy of PREPARE across a range of health
statuses.
The SFVAMC Veteran population consists of approxi-
mately 4 % women [1]. Therefore, we increased recruit-
ment of women by working closely with the SFVAMC
Women’s Clinic and oversampling women through our
patient recruitment call lists. To ensure a diverse sample,
we also oversampled minorities in an attempt to obtain a
cohort of 50 % white and 50 % non-white Veterans. Over-
sampling is feasible as the racial/ethnic variation of
SFVAMC outpatients is approximately 55 % white, 29 %
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black, 8 % Latino, 6 % Asian/Pacific Islander, and 2 %
other [26].
For a subset of enrolled participants, we also include
Veteran’s self-identified surrogate decision-makers.
Surrogates are included if the Veteran identifies her
or him and gives the study team permission to contact
them. Surrogates are excluded if they had dementia
or are blind, deaf, or psychotic as determined by the
study staff (Table 1).
Recruitment
Health Insurance Portability and Accountability Act
(HIPAA) waiver
To facilitate recruitment, we obtained a HIPAA waiver to
access data from VA administrative records on patients’
names, age, race/ethnicity, gender, phone numbers,
addresses, medical record numbers, ICD-9 codes, dates of
outpatient primary care clinic appointments in the past
year and up to 3 months in the future, hospitalizations
and emergency room visits in the past year, and the name
of their outpatient primary care provider. All data is stored
on secure, password-protected servers or in locked
research offices. Access is restricted to the study team for
recruitment purposes only.
Data extraction
After obtaining a HIPAA waiver, we obtained a list of
potential Veteran participants who met initial eligibility
criteria described in Table 1 and a list of their primary
care physicians.
Fig. 1 Flowchart of the PREPARE Trial
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Clinician involvement
Upon completion of the administrative data pulls and
identification of potentially eligible Veterans, primary
care providers are then sent an e-mail letter inform-
ing them about the research study. The email also
asks providers to give their permission for our study
staff to contact their patients and tell them more
about the study. A list of the clinician’s patients is
provided, and clinicians are given the option to opt
out for all patients, approve for all of their patients,
or review the patient list to identify individual
patients whom they feel are either appropriate or
inappropriate for our study. We also ask permission
of clinicians to allow us to send their potentially
eligible patients a recruitment letter stating that the
clinician gave permission to tell them more about a
research study. Clinicians can opt out of having their
name used in the patient recruitment letter. Clinicians
are informed that if they did not respond to our
emails or phone calls within three attempts, we will
assume assent for the study. If clinicians do not
respond after three attempts over 3 weeks to our
requests to grant permission to contact their patients,
we send a generic, nonpersonalized recruitment letter
describing the study to potential participants on
behalf of the study team. If a clinician gives us expli-
cit permission to contact their patients, we inform
patients that their individual doctor gave us permis-
sion to contact them and tell them about the study.
Otherwise, we describe the study without mentioning
their clinician.
Targeted patient recruitment by letter
The recruitment letter to patients describes the research
study and gives patients a toll-free telephone number to
call to opt-out or to hear more about the study. Potential
participants who do not call study staff to decline
participation within 1 week of the mailings are deemed
eligible to be contacted by phone to further describe the
study and assess willingness to participate and study
eligibility. Additional waves of patient recruitment letters
will be sent out two to three times per year to enhance
our recruitment efforts.
Table 1 Inclusion and exclusion criteria by type of study
participant
Veteran patient
Inclusion criteria 60 years of age or older
Obtains care in the primary care clinics (General
Medicine, Geriatrics, and Women’s Clinic) at the
San Francisco VA Medical Center
Has been seen at least twice in the last year by a
primary care provider (a measure of established
primary care) and had at least two additional visits
to the VA in the past year (a measure of frequent the
medical center)
Exclusion criteria Dementia by ICD-9 codes, clinician assessment, chart
review or self-report
Blindness or poor vision by ICD-9 codes, clinician
assessment, chart review, self-report of blindness or
the inability to read print on a newspaper, or research
staff assessment of less than 20/200 vision on the
Snellen eye chart with corrective lenses [42].
Deafness by ICD-9 codes, clinician assessment,
self-report, chart review or research staff assessment
Cognitive impairment as assessed by research staff of
any deficits on the validated cognitive assessments
Short Portable Mental Status Questionnaire (SPMSQ)
[43] and the mini-Cog [44]
Delirium or psychosis as assessed by a clinician or
research staff
Does not report fluency in English
No phone for additional study contacts and follow-up
interviews
Active drug or alcohol abuse within the past
3 months determined by clinician assessment,
self-report, chart review or research staff assessment
Patients who report they will be out of town during
their scheduled follow-up interview dates outside of a
window of 2 months
Patients who cannot answer consent teach-back
questions after three attempts
Surrogate participant
Inclusion criteria 18 years of age or older
An enrolled patient must identify the surrogate as
someone who could make medical decisions for him
or her if needed
An enrolled patient must give the surrogate’s contact
information and give permission to contact their
potential surrogate
Exclusion criteria Self-reported dementia, blindness, or deafness
Cognitive impairment as assessed by research staff of
any deficits on the validated cognitive assessments
Short Portable Mental Status Questionnaire (SPMSQ)
[43] and the mini-Cog [44]
Delirium or psychosis as assessed by research staff
Does not report fluency in English
No phone for follow-up interviews
Surrogates who report they will be out of town
during their scheduled follow-up interview dates
outside of a window of 2 months
Table 1 Inclusion and exclusion criteria by type of study
participant (Continued)
Surrogate for whom we cannot schedule an interview
greater than 6 months from the Veteran’s final
6-month follow-up interview date
Surrogates for whom we have attempted to contact
5 times or more without a response
Surrogates who cannot answer consent teach-back
questions after three attempts
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Targeted patient recruitment by phone
We attempt to schedule Veterans for the baseline interview
and exposure to the intervention 1 to 3 weeks prior to their
next upcoming primary care appointment. This is done to
standardize the timing between intervention exposure and
primary care follow-up. Therefore, for Veterans who do not
send back an opt-out letter or call to refuse participation,
we attempt recruitment by phone. Targeted data pulls are
created to determine which Veterans have upcoming
primary care appointments at least 2 weeks in the future.
This time frame was selected to allow time to screen and
schedule consent and baseline interviews 1 to 3 weeks prior
to the primary care visit. The order of Veterans’ names on
the recruitment call lists is randomly “scrambled” to pre-
vent biased sampling. In addition, women and minority
Veterans are prioritized on the call list in an attempt to
oversample during phone recruitment.
Recruitment fliers
Study-related fliers written at a 5th-grade reading level
are posted in approved areas in the primary care clinics
at the SFVAMC. Potential participants who read a study
flier can opt-in to the study by contacting study staff via
our toll-free number.
Surrogate recruitment
Once Veterans are enrolled in the study, we obtain a
consecutive sample of English-speaking surrogates
through Veteran referral. For Veterans who grant us per-
mission to contact their potential surrogate, we obtain
contact information for the surrogate from the enrolled
Veteran. We also ask the Veteran participant to give the
potential surrogate participant our study flier and/or let
them know we would be contacting them. Depending
upon the type of contact information we are given by
the Veteran, we may contact the potential surrogate
participant in the clinic, if they accompanied a Veteran
participant, or by phone, email, or mail.
Screening for eligibility of Veterans and surrogates
Interested Veteran participants and surrogates are
screened for eligibility based on the exclusion criteria in
Table 1. Specifically, research staff exclude individuals
who report not having a phone, Veterans who are less
than 60 years of age, and Veterans or surrogates who
test positive for moderate-to-severe cognitive impair-
ment on the Short Portable Mental Status Questionnaire
(SPMSQ) as indicated by more than three errors and
who then also fail to recall at least two out of three
items on the three-item recall of Mini-Cog [27, 28].
Participants are also excluded if they self-reported
having dementia, poor vision (unable to see the words
on a newspaper), or being unable to speak English well
or very well.
Consent procedures
Written consent for patients
Informed consent will be or has been obtained from all
study participants. We use a modified consent process
we designed to help vulnerable populations make
informed decisions about study participation [29]. This
process involves using a consent form written at a 5th-
grade reading level, reading and paraphrasing the consent
form to potential subjects, allowing time for questions and
discussion, and then assessing comprehension about the
study via the teach-back method. Patients are also
able to read the form independently if they wished. If
comprehension questions during teach-back are not
answered correctly, repeated education and reassess-
ment of comprehension are continued until complete
comprehension is achieved. If subjects cannot pass
the teach-back process and comprehension assessment
after three attempts, the patient is deemed ineligible
for the study.
Electronic or written consent for clinicians to be
audio-recorded
We obtain either an e-consent or written consent for
clinicians to be audio-recorded during primary care
visits, to answer one demographic question about their
race/ethnicity, and to allow us to contact them in the
future if we have further questions about their enrolled
patients. The e-consent is emailed to clinicians on
secure email servers. If clinicians cannot be reached by
email, we obtain written consent in-person.
Verbal and written consent for surrogates
Some patients’ surrogate decision-makers may live outside
of the area (in a different state), or cannot come to the VA
for in-person informed consent. Initially, a waiver of
signed consent for surrogates was not approved. At this
time, a signed written consent form is required prior to
any surrogate interviews. To accomplish this, we mail a
consent form to the surrogate, review the consent form
and conduct consent verification over the phone. The sur-
rogate is then given a stamped and addressed envelope to
return the signed consent form. After consent is obtained,
we can then call and schedule a phone or in-person inter-
view. This is time consuming and can result in several (up
to 10) attempts to contact the surrogate. Therefore, we
now obtain a written consent waiver for surrogates. After
calling a potential surrogate participant, if they answer all
questions on the consent verification accurately within
three tries, the surrogate can provide verbal consent over
the phone, and we can continue with the study interview.
If the surrogate is available in person, then a written in-
formed consent form is reviewed and signed. All surro-
gates are still required to complete and return a signed
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HIPAA authorization by mail for their interview informa-
tion to be used in the study.
Intervention and control conditions
After the baseline interview, participants in the PREPARE arm
review the PREPARE website (www.prepareforyourcare.org)
in the research offices. Research staff are available to
answer questions, but participants are asked to go
through the PREPARE website (Steps 1 through 5) on
their own and in its entirety. As participants progress
through the website, PREPARE asks questions about
overall life values and goals for medical care. At the
end of the program, the participant is asked to make
an action plan to do one ACP task in the next weeks
to months. At the end of the interview, research staff print
out the action plan and a summary of the Veteran’s
medical wishes and compile this into a folder that also
contains the PREPARE pamphlet, booklet, DVD, and the
log-in code to the website. The PREPARE DVD contains
the same information found on the website, but without
interactive or tailored functionality. PREPARE arm partici-
pants are also given an easy-to-read advance directive to
review and take home (http://www.iha4health.org/our-
services/advance-directive/) [13]. Participants in the
control arm are only given the advance directive, are asked
to review it for at least 10 minutes and to take it home.
The control arm is not given any information about the
PREPARE materials. One to 3 days before the Veteran’s
next scheduled primary care appointment, research
staff call the PREPARE arm participants to remind
them to bring in their action plan, summary of wishes
and advance directive to their doctor’s appointment.
For the control arm, research staff members only
remind Veterans about their upcoming primary care
appointment.
Randomization procedures
We block randomize Veterans based on limited health
literacy, as determined by a validated question concerning
confidence with medical forms [30], and non-white race/
ethnicity to ensure these variables are equally distributed
between randomization groups. A statistician not involved
in recruitment or data collection used a computer-based
random number generator to create a randomization
scheme within four groups (high health literacy and white
race/ethnicity, high health literacy and non-white race/
ethnicity, low health literacy and white race/ethnicity,
and low health literacy and non-white race/ethnicity)
in random block sizes of 4, 6, and 8. This randomization
scheme was imported into the Research Electronic Data
Capture (REDCap) software by the statistician. Only the
research personnel who conducted the baseline interview
use this software prior to the baseline interview to deter-
mine which study arm the Veteran is assigned to and
which ACP interventions (PREPARE versus control) to
give the enrolled participant. Randomization information
is kept separate from other research or identifying Veteran
data and is only associated with a unique Veteran identifi-
cation number.
Blinding
Participants are blinded to group assignment. They are
told that the purpose of the study is to help patients
make difficult medical decisions, and that each participant
would review one of two guides. This blinding is enhanced
by each group obtaining some form of ACP materials,
such as the easy-to-read advance directive. To ensure
blinding of research staff for all follow-up outcome assess-
ments, staff who had completed the baseline interview
and randomization for a given participant will not conduct
any follow-up interviews with that participant.
Intervention fidelity
A study protocol manual was created for research staff,
and several training sessions have been and will continue
to be conducted until the end of the study. In addition,
we have created standardized study scripts for recruit-
ment and interviewing and have created training videos
to standardize the study procedures. Checklists for all
follow-up assessments have also been created. All staff
being trained need to learn each item on the checklist,
shadow other study staff, and be evaluated by their
supervisors for each checklist item. Study staff cannot
conduct PREPARE study tasks independently until they
can demonstrate mastery of each checklist item. After
study staff members are considered independent to
conduct study tasks and interviews, a 10 % random
sample of interviews will be observed to ensure fidelity
to study procedures. Data collection initially began with
paper surveys that were entered into a REDCap survey
capture database. At least 50 % of the data entry was
reviewed by an independent staff member to ensure data
were entered correctly. Part way through our study, we
switched to live data capture through REDCap. This
allows us to streamline our data entry procedures and
reduce the use of printed paper surveys. To reduce miss-
ing data, automatic prompts have been created within
the REDCap program that will not allow study staff to
progress if a question is left blank. Concerns about
question wording or response option interpretation are
reviewed at regular team meetings.
Ethics
This study has been approved by the University of
California, San Francisco (UCSF) and the San Francisco
VA Medical Center institutional review boards (UCSF IRB
reference # 10-00098) and is registered at ClinicalTrials.-
gov (NCT01550731). This study is funded by the United
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States Veterans Administration, Health Services Research
and Development.
Measures and data collection
A range of measures are collected to capture the full
process of ACP and whether the PREPARE intervention
has any effect on ACP, medical decision-making, patient
activation, clinician responsiveness, and doctor-patient
communication. Table 2 lists all study measures assessed
at multiple time points. Details of the main outcome
measures are described below.
Measures related to advance directive and ACP
documentation
Standard ACP is measured by the completion of advance
directives in the VA electronic medical record. We will
assess baseline advance directive completion rates and
the date the advance directive was signed as well as ACP
discussions. At 6 months (date of the last follow-up
interview), we reassess the advance directive completion
rate and the date it was signed to determine length of
time from study enrollment to documentation. An
advance directive for the purposes of this study includes
the VA or easy-to-read advance directive, a living will, a
durable power of attorney for health care document
(DPOAHC), a Physicians Orders of Life Sustaining
Treatment form, or other documentation of the patient’s
wishes for medical care (code status, such as full code
or do not resuscitate or do not intubate orders by a
physician).
Measures related to ACP engagement including behavior
change process measures and ACP actions
Full ACP engagement is measured by Veteran self-report at
baseline, 1 week, 3 months, and 6 months. Based on Social
Cognitive Theory and Behavioral Change Theory [18, 19], we
included measures to capture theoretical constructs related
to contemplation of behavior, planning or intention to act on
the behavior, and the behavior itself. If only the action behav-
ior is measured, such as completion of an advance directive,
clinically significant movement along the behavior change
pathway will be missed. Thus, it is important to ascertain
ACP process measures of behavior change (knowledge, con-
templation, self-efficacy, and readiness) for several ACP ac-
tions in addition to whether they have completed an ACP
behavior (Action Measures). These actions include 1) identi-
fying of a surrogate, 2) identifying values and goals, 3) choos-
ing the level of leeway or flexibility in decision-making for
the surrogate, 4) and communicating this information with
clinicians and surrogate decision makers, and 5) docu-
menting one’s wishes [22]. As Veterans may have had
varying degrees of experience with ACP, we assess baseline
engagement in ACP within the past 5 years (standardized
based on pilot data). We also ask about engagement in
ACP since the randomization date, for example, “Within
the past one week, 3 or 6 months”, depending upon the
follow-up interval.
Validity and reliability of the ACP Engagement Survey
In a prior study, we established the validity and reliability of
the ACP engagement survey in 50 older adults, aged 60 years
or older with two or more chronic or serious illnesses (32 %
female, 42 % non-white). Internal consistency of the survey
was high with a Cronbach’s alpha of 0.94 for Process Mea-
sures. Seven-day test-retest reliability was also high with in-
terclass correlations of 0.70 for Process Measures and 0.87
for Action Measures. We also tested discriminant validity by
comparing process and action scores for older adults to
healthy young adults and found statistically significant differ-
ences [22]. Furthermore, this survey has been used in pilot
testing and has been shown to be able to detect ACP behav-
ior change in response to the PREPARE website [15].
Measures related to engagement and satisfaction in
decision-making
Engagement in decision-making is measured with two items
(Table 2, desired role in decision-making). Satisfaction with
decision-making is assessed with the Decisional Conflict
scale for those who report a decision was made [31]. The
Decisional Conflict scale consists of three subscales assessing
decisional uncertainty, factors contributing to uncertainty,
and decisional effectiveness.
Measures related to surrogate decision maker reports of
Veteran engagement
Because the preparation guide is highly focused on commu-
nication with one’s surrogate, it is important to measure
whether Veterans engage in preparation behaviors with
his/her potential surrogate for important corroborating in-
formation. We ask yes/no questions for all 5 preparation
domains (Table 2, surrogate reports of patient engagement
in ACP and other surrogate items). Surrogates are also
asked about their knowledge of the Veteran’s wishes and
confidence in making decisions on the Veteran’s behalf on
a 5-point Likert scale with response options from “not at
all” to “extremely”.
Measures related to acceptability and usability of PREPARE
versus control
Acceptability and usability of PREPARE compared to an ad-
vance directive alone are measured with validated scales
from our prior work according to the following: (a) ease of
use and understanding (8-item scale), (b) personal usefulness
in treatment decisions and discussions (6-item scale), and (c)
attitudes about norms or expectations (6-item scale) [12].
We also assess how comfortable the Veterans are in com-
pleting the forms and the website, how helpful they find the
materials, and how likely they are to recommend the
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Table 2 Constructs and measures for evaluating the efficacy of the PREPARE Study
Construct Measure # items Reliability/validity Screener Baseline 1 week 3 month 6 month
Eligibility screening variables
Cognitive impairment Short Portable Mental Status
Questionnaire (SPMSQ)
7 Sensitivity 86.2 %,
specificity 99.0 % [43]
X
0 to 2 = eligible
3 to 7 moderate impairment (go on
to the Mini Cog three-item recall)
≥8 severe impairment = ineligible
Cognitive impairment
(participants scoring
3 to 7 errors on the
SPMSQ)
Mini Cog (three-item recall as
needed, if SPMSQ screen + for
cognitive impairment)
3 Sensitivity 76 %,
specificity 89 % [44]
X
If recall≥ two words = eligible




Demographic information Age, gender, race/ethnicity [45],
income, marital status, and education
X X
Health literacy screen “How comfortable are you filling
out medical forms by yourself?”
1 AUROC 0.80




“Qué tan seguro (a) se siente al llenar
formas usted solo (a)”
Health literacy assessment Short form Test of Functional Health
Literacy in Adults s-TOFHLA, scores
0 to 36) [47] Continuous &
dichotomized to limited = 0 to 22
and adequate = 23 to 36
36 Cronbach’s α= .97 X
Correlation
coefficient w/ other
literacy tests > 0.80 [47]
United States acculturation Based on Acculturation scale (USAS)
“How many years have you lived in
the U.S.?”
1 Cronbach’s α= .98 X
Associated w/ desire to
know prognosis [48]
Finances “In general, how do your finances






Socioeconomic status and social standing Social standing ladder (that is, place
an “x” where you think you stand




Functional status Activities of Daily Living (ADL) and





Self-rated health status In general how would you rate
your health? (5-pt Likert)





Self-rated quality of life In general, how would you rate your
overall quality of life in the past
week (5-pt Likert)
1 Test-retest
coefficient = 0.81 [54]
X
Comorbid illness Determined by ICD-9 codes (chart) 0 Mortality c-stat: [23] X
Charlson comorbidity score [24] Charlson = 0.704
Elixhauser comorbidity score [55] Elixhauser = 0.793





Religion/spirituality Self-reported extent of how
spiritual/religious (5-pt Likert)
and role play in decision-making.
4 Spirituality associated






Prior ACP experience Prior ACP experiences (for example,
Ever had to make life threatening
medical decisions?”) [12]
5 X
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Table 2 Constructs and measures for evaluating the efficacy of the PREPARE Study (Continued)
Construct Measure # items Reliability/validity Screener Baseline 1 week 3 month 6 month
Major life changes For example, “In the past 6 months,
have you or someone close to you
been faced with a serious medical
problem or diagnosis?”
4 X
Mediator variablesa (also measured
as Outcome Variables)
Baseline knowledge Knowledge subscales of the
ACP Engagement Survey.
6 Cronbach’s α= 0.84
(0.76-0.90), ICC = 0.70
(0.50-0.82) [15]
X
Baseline self-efficacy Self-efficacy subscales of the
ACP Engagement Survey.
6 Cronbach’s α= 0.83
(0.75-0.89), ICC = 0.60
(0.41-0.76) [15]
X
Baseline readiness Readiness subscales of the
ACP Engagement Survey.
10 Cronbach’s α= 0.92
(0.88-0.95), ICC = 0.60
(0.53-0.81) [15]
X
Baseline barriers Checkbox of 13 common barriers 13 Associated with
ACP [25]
X















116 Process Measures: Cronbach’s
α= 0.94 (0.91-0.96),
ICC = 0.70 (0.54-0.82) [15]
X X X X






Communication quality Modified CAHPS (that is, did this
provider explain things in a way
that was easy to understand?)
14 Comparative Fit
Index = 0.98, Tucker
Lewis Index = 0.98
X X
Internal consistency:
0.58 to 0.92. ≥ 0.70




For example, “How satisfied are you
that you could share your most
important concerns with X/that X
understood what was most
important to you?)
8 X X X X
Satisfaction with care Care Consistent with Goals:
Comparison of 10-point ratings about
aggressiveness of care desired and
care currently receiving.
4 X X
Barriers to ACP Checkbox of 13 common barriers
(for example, thinking about the
topic makes me nervous or sad; I am
too healthy; I am too busy; my family
or doctor is too busy; I prefer to
leave my health in God’s
hands; I don’t want to
burden my family and
friends; I want to leave
the choice to my friends
and family; I want to leave






Attitudes about ACP Processes of change for
ACP [16]
34 Responsive to ACP
intervention [15]
X
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Table 2 Constructs and measures for evaluating the efficacy of the PREPARE Study (Continued)
















for total scale. 0.58-
0.92 for subscales [31]
Depression and anxiety Patient Health Questionnaire
(PHQ-4)
4 Cronbach’s α= 0.78 [63] X X X X
Surrogate reports of patient
engagement in ACP and
other surrogate items
Modified from the ACP
Engagement Survey [22],
(for example, “Did [Veteran]
ask you to be their surrogate
decision maker, talk to you
about leeway, talk to you
about their values, tell other
family or friends about their
wishes, ask clinicians questions









Acceptability and Usability 1 factor explained




(a) Ease of use and understanding 8
(b) Usefulness in decisions
& discussions
6
(c) Attitudes about norms
or expectations
6
for example, “Did you try to fill out
the advance directive we gave you?”
“Did you give it to a medical provider,
social worker, or case manager?”
If they respond no, “Why do you
think you did not turn it in?” “What
can we do to get other people to
look over these materials?” “What
would motivate them?” “What




Feasibility (Control) (for example,
when and where to review
ACP materials)
7 X
Feasibility (PREPARE only) (for
example, when and where to
review ACP materials,
and which PREPARE materials
did you use and would recommend)
34
“Do you remember what your
action plan was?”
“Did you complete your action plan?”
If no to completing an action plan,
“Why do you think you have not
completed your action plan?”
“After the first study visit, did you
look at the (action plan, summary
of your wishes, the PREPARE website,
pamphlet, Booklet/or DVD) again?
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materials to others [32]. These outcomes are important to
measure to ensure PREPARE will be used in clinical practice
and in the community.
Measures related to Veteran activation within primary
care encounters
Veteran activation within the clinical encounter is assessed
by audio-recording primary care visits using Dr. Richard
Street’s communication coding system. This system defines
activation as the degree to which patients ask questions, ex-
press concerns, offer opinions, state preferences, introduce
new topics, or make decisions [33]. These behaviors are
considered active because they have been shown to influ-
ence clinician’s behavior and treatment decisions [19]. We
are interested both in activation in general throughout the
consultation and in any discussions of ACP [34]. Therefore,
we will assess overall activation and ACP-specific activation.
The number of activation utterances will be assessed by in-
dependent, blinded coders and will be included in a compos-
ite measure. Utterances will also be coded as “self-initiated”
or “prompted”, depending on whether the activation was
solicited or encouraged by the physician. An increase of one
patient activation utterance is considered clinically relevant.
The codes of patient activation will be transformed into
quantitative data and stored in a relational database that can
be exported for quantitative analysis. To protect against
rater drift and decay, continuous monitoring of inter-rater
reliability will occur throughout the entire coding period by
double-coding 20 % of the conversations. The coders will re-
solve any coding disagreements by conference; the entire
team will resolve persistent disagreements.
Measures related to clinician responsiveness within primary
care encounters
Clinician’s responsiveness within the clinical encounter
will be assessed by rating “informativeness”, participa-
tory decision-making, and partnership building. Overall
informativeness will be rated on a 5-point Likert scale by
two independent raters from recordings using Dr. Street’s
previously validated measure based on whether the clin-
ician fully discusses what is causing the patient’s problem,
the clinician explains everything to the patient, the clin-
ician is very informative about the patient’s health, and the
clinician’s recommendations are clear and easy to under-
stand (score 4 to 20) [34, 35]. ACP-specific informative-
ness is adapted from this measure and uses the following
three items: the clinician thoroughly explained everything
about the ACP topic discussed, the clinician was very in-
formative about ACP, and the clinician’s explanations
about ACP are very clear (score 3 to 15). Clinician’s
participatory decision-making/partnership building is
adapted from Kaplan by Dr. Street [34, 35]. For this
measure, independent raters will decide on a 1 to 10 scale
(1 = not at all and 10 = a great deal) whether the clinician
involved the Veteran in the decisions, gave the Veteran a
sense of control over medical care, and asked the Veteran
to take some responsibility for ACP or medical care
(scores 3 to 30).
Measures related to barriers and facilitators of ACP and
PREPARE dissemination
Perceived barriers to engagement in ACP behaviors are
assessed with a 10-item survey of the common barriers
defined in our prior work and other studies [25].
Input about implementation
Input about implementation is assessed at 6 months by
asking Veterans in the PREPARE arm questions about
the acceptability and usability of PREPARE (for example,
when and where to review ACP materials, and which
PREPARE materials did you use and would recommend).
For Veterans in the control arm, we ask about imple-
mentation of the ACP materials (for example, when and
where to review ACP materials). For Veterans in the
PREPARE arm, similar questions are asked of their
surrogate decision-makers about the Veterans’ use of the
PREPARE materials and the surrogates’ opinions.
Table 2 Constructs and measures for evaluating the efficacy of the PREPARE Study (Continued)
Construct Measure # items Reliability/validity Screener Baseline 1 week 3 month 6 month
If no, “Why do you think you didn’t
you look at it?”
Satisfaction questions include
“Which of the PREPARE materials
was the most helpful?”; “Which
would you use again?” “Which
did you share with your decision
maker, friends, or family?” “When
is the best time to see the PREPARE
materials?” “Where do you think most
people would prefer to review the
PREPARE materials (home, clinic,
or public space)?
aWhereas the mediator variables, measured at baseline, may explain how or why a particular effect or relationship occurs, these variables may also be affected by the
intervention and are therefore also measured as outcome variables
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Outcomes and Sample Size Calculations
Primary outcome
The primary outcome is advance directive documenta-
tion in the medical record. This outcome was selected
based on prior studies that have shown that advance
directive interventions can increase documentation. A
meta-analysis demonstrated a pooled effect size of 0.50
(95 % CI; 0.17-0.83) suggesting a positive effect associ-
ated with advance directive interventions [36]. One RCT
of an ACP workbook in older Veterans also demon-
strated an increase in living wills documented from 23 %
in controls to 48 % in the intervention group (P < .001);
and ACP notes from 24 % to 47 % (P < .001) [37]. Con-
sistent with results from prior studies, our pilot study
showed that a literacy appropriate advance directive
doubled completion rates from baseline [12]. From
SFVAMC administrative data, 11 % of the potential
study sample had an advance directive in their medical
record. We assume that after being included in the study,
the control group may have an advance directive docu-
mentation rate of 15 %. If we assume doubling of the per-
cent of ACP discussion notes between groups (what we
consider clinically significant), a sample size of 350, or 175
in each arm, will afford us 92 % power with a two-tailed
alpha of 0.05 to detect an elevation in rate of advance dir-
ective documentation from 15 % in controls to 30 % in
the PREPARE group and 80 % power to detect a difference
of 15 % in controls versus 27 % in the PREPARE group.
After accounting for an estimated 15 % attrition rate, in-
cluding death at 6 months (based on prior work) [12], our
recruitment target is 410 Veterans or 205 in each arm.
Secondary outcomes
The secondary outcomes of this study include a compre-
hensive range of five specific ACP behaviors: 1) identifica-
tion of a surrogate, 2) identification of values and goals, 3)
choosing the level of leeway or flexibility in decision-
making for the surrogate, 4) communicating this informa-
tion with clinicians and surrogate decision-makers, and 5)
documenting one’s wishes. We hypothesize that the scores
from these ACP engagement items could be 50 % higher
in the PREPARE group compared to the control group.
Based on a pilot, the mean engagement scores for older
outpatients were 30.7 points out of 57 ± SD of 10. There-
fore, we expect a mean score as high as 40 points, a 10-
point average difference between PREPARE and controls.
However, even an increase of three points may represent a
new action in any of the five domains. Using a two-tailed
alpha of 0.05, 175 veterans in each randomization group
will give us > 99.9 % power to detect a 10-point difference
in engagement score, 96 % power to detect a four-point
difference, and 80 % power to detect a three-point differ-
ence. A sample size of 350 will also allow us to assess each
of the five domains of the preparation engagement survey
separately as dichotomous variables, “action taken/no ac-
tion taken”. If we assume a doubling of the percent of Vet-
erans who “took action” within each of the five domains,
using a two-tailed alpha of 0.05, we estimate that 175 vet-
erans in each randomization group will give 92 % power
to detect a doubling in the percent of Veterans who “took
action” from 15 % (controls) to 30 % (PREPARE group)
and 88 % power to detect a difference of 15 % versus 27
%. Taking into account an anticipated 15 % drop out as
describe above, our anticipated 410 Veterans or 205 in
each arm will provide us ample power to assess these
outcomes.
The sample size of 350 Veterans will also allow
adequate power to assess interactions based on potential
moderating variables (race/ethnicity, literacy, gender)
for our outcomes. We also anticipate very low intra-
clinician correlations due to clustering or contamination;
randomization is at the patient level not at the clinician
level, and intra-clinician correlation values for patient
attitudes and knowledge are typically quite low even in
physician-level cluster randomized trials (for example,
0.015) [38]. Furthermore, as we have a potential pool of
115 clinicians, most clinicians will care for no more than
one to three eligible Veterans and thus, there will be
negligible loss of effective sample size accounting for
clustering and contamination.
In exploratory analysis to corroborate Veteran reports
of activation, we will attempt to recruit 144 surrogates
(72 in each arm) anticipating that 20 % of Veterans will
not have identified a surrogate based on pilot data, 15 %
of Veterans will be lost to follow-up, and 30 % of surro-
gates will refuse. For patient activation within clinical en-
counters, we will attempt to audio-record 200 Veterans
(100 in each group) to account for potential 25 % of
enrolled Veteran and 25 % clinician refusal rates. For
input about implementation, we anticipate recruiting
175 Veterans in the PREPARE arm (accounting for a
15 % drop-out at 6 months) and 72 of PREPARE arm
Veteran’s surrogates.
Timeline
Figure 2 shows the timeline of the trial. We started
recruitment in April 2013 and will end recruitment of
Veterans in September 2015. We are currently undergoing
recruitment of surrogate participants and expect to
complete recruitment in September 2016.
Data analysis
RCT efficacy analysis
Our primary analyses will compare advance directive
completion rates and change in engagement in the five
ACP behaviors (see Primary outcome section) using be-
havior change measure scores on a 5-point Likert scale
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(analyzed as average Likert scores and total scores of 57
to 285) and action measure scores using yes and no re-
sponses (scores 0 to 25) from baseline to 1 week, and 3,
and 6 months between study arms. We first will use
means, medians, and ranges to describe continuous
variables, and we will use proportions to describe
categorical and dichotomous variables. Baseline com-
parability of the two groups will then be assessed
using t-tests for continuous variables and chi-square
tests for proportions. To examine the outcomes
between the two study arms longitudinally, we will
use mixed effects linear, Poisson, or negative bino-
mial regression for continuous outcome measures
and mixed effects logistic regression for dichotomous
measures. The mixed effects models will include a
random effect for subjects and fixed effects for the
primary modeling terms of time, study arm, and an
interaction term of study arm and time. We will treat
the time variable in three different ways: (i) our first
model will encode the time variable as a dummy
variable for baseline versus the post-intervention
time points; (ii) we will next model time in a con-
tinuous linear fashion; (iii) we will lastly consider an
arbitrary time course by treating time as a categorical
factor variable. We will also adjust for the
randomization blocking factors of health literacy
(limited versus adequate) and race (white versus non-
white) [39] and for any predictor variables that differ
between study arms at baseline. We will also include
random physician intercepts to account for nesting of
patients within physicians. We will consider includ-
ing random effects for the primary modeling terms
of time, study arm, and their interaction. Modeling
decisions (for example, which mean structure to use
and which random effects to include) will be based
on comparing values of the Akaike Information Cri-
terion. Models will be fit using the xt routines in
Stata. Mediation analyses will use Stata’s mediation
package, which allows estimation of the average causal
mediation effect using a potential outcomes framework
with either continuous or binary outcomes and allows for
sensitivity analyses with respect to violation of the sequen-
tial ignorability assumption [40]. Moderating variables will
be tested with interaction terms.
Quantitative assessment of patient activation within
clinical encounters
Differences in the number of patient activation utterances,
ACP topics discussed, and length of time discussed will be
compared between groups using mixed effects models as
above with a random intercept for physician. Clinician
race/ethnicity, and gender will be included as covariates as
these variables are associated with doctor-patient commu-
nication [41]. We will also obtain the number of utter-
ances that may signify clinician contamination (knowledge
of study arm) to control for these findings.
Discussion
This is the first study to test the efficacy of a new paradigm
of ACP focused on preparing chronically ill older Veterans
for communication and medical decision-making as opera-
tionalized in the PREPARE website. The development of
the PREPARE was based on extensive published formative
research in which the community, key stakeholders, and
the target population were included in the development of
the website. Designed to be easy-to-read and to include
culturally competent material, PREPARE is also unique for
its user-friendly features such as the use of video modeling
of ACP behaviors, tailored and interactive content based
on values and decision preferences, and the opportunity to
create an action plan for change.
There have been a few logistic challenges to date.
Although we attempt to schedule Veteran’s baseline
appointment and randomization 1 to 3 weeks prior to
their most proximate primary care appointment, this, at
times, has been difficult to implement for various
reasons. For example, some Veterans reschedule their
baseline interview resulting in the intervention occurring
within a few days before their clinic visit. Other Veterans
or the clinic will cancel a primary care appointment after
the baseline interview has occurred resulting in a time
frame beyond the three-week ideal. We will adjust for
these varying time frames from exposure to the inter-
vention in our analyses. In addition, because the audio-
recording occurs at the primary care visit and because
several primary outcomes of the study would occur at
the primary care visit, we decided to make the primary
care visit the date from which all follow-up interviews
would be calculated. Because follow-up of the 1-week,





































Fig. 2 PREPARE Study Timeline
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3-month and 6-month interviews within defined time
frames was proving challenging, we decided to allow
a range of dates that were acceptable. For instance, if
a primary care appointment is rescheduled is outside of
the ideal 1-3 week window from the baseline interview
and randomization, we will audio-record the primary care
appointment up to 6 months after the baseline interview,
but not after. For the one week follow-up interviews, the
allowable Veteran interview range was changed from as
early as 5 days from their primary care appointment to as
late as 2 weeks prior to their 3-month follow-up; for the
3-month interview the range is from as early as 2.8
months from the primary care appointment to as late
as 2 weeks before the 6-month interview; and for
their 6-month interview, the ranges is from as early
as 5.8 months from the primary care appointment to
as late as 9 months from the appointment.
As described in the methods, surrogate recruitment
was initially challenging without the ability to obtain ver-
bal consent. However, this was approved by the IRB of-
fice part way through the study. Because surrogate
contact takes a great deal of time, we have extended the
surrogate recruitment date range to up to 6 months after
the Veteran had completed their last 6-month follow-up
visit. Even so, there have been several surrogates who
were interested but never returned the consent mate-
rials, or who returned the consent materials but could
not be scheduled before the 6-month cut off. We are
hoping that verbal consent will make surrogate inter-
views easier to obtain.
In addition to testing PREPARE, we hope to be
able to disseminate the website broadly. By assessing
satisfaction with the PREPARE materials and suggestions
for implementation and dissemination during the ran-
domized trial phase, should the results be positive, we
hope to move from the efficacy trial phase quickly to im-
plementation and dissemination within the VA and the
community.
If PREPARE proves efficacious in helping Veterans
engage in ACP, communicate their wishes, better prepare
themselves and their loved ones for complex medical
decision-making, and document their wishes in the
medical record, the PREPARE website could prove to be a
scalable and effective intervention to improve the care of
older Veterans and ensure Veteran’s wishes are honored.
Because PREPARE can be used outside of the clinical
environment, in future studies it may also save clinicians
time and prove to be cost-effective.
Trial status
This trial is in the active recruitment phase. While we have
completed recruitment of 410 Veterans, we anticipate
ending surrogate recruitment in September 2016.
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